Plasma exchange with human serum albumin 5%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Plasma exchange with human serum albumin 5%, covering 2026-06-04 to 2026-06-04. Get the full timeline:
Most recent: Clinical Trial Results: Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% [Phase 3]